Excision BioTherapeutics has shared data from the first human clinical trial of a CRISPR cure for HIV. Here's what we know — and don't know.
  • Nougat@kbin.social
    3·
    11 months ago

    Seems like the main point of this report is that none of the people who’d been given the treatment suffered any ill effects, and that the “stuff” of said treatment remained detectable in them after four weeks. They promise to have additional data in 2024.